The clinical significance of many of the inherited mutations that can now be identified remains unclear.

A new approach to prognosis looks to patients’ genomes for clues about how their cancer will behave.

Genomic tumor profiling in pediatric patients can clarify diagnosis and treatment, a recent study found.

In a small trial, Jemperli led to complete remission in people with a biomarker for deficient DNA repair.

Pediatric patients were matched to therapies targeting specific mutations found in their cancers.

Study confirms that Black men are at higher risk for prostate cancer disease progression and death.

A look back at some of the most important science and treatment news Cancer Health covered this year.

Next-generation genomic testing improved the effectiveness of targeted therapies for certain patients with metastatic breast cancer.

Targeted therapies are available for eight tumor mutations, highlighting the importance of genomic testing.

National Cancer Institute study describes three molecular subtypes of lung cancer in people who have never smoked.